<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04850326</url>
  </required_header>
  <id_info>
    <org_study_id>AP-R-2019-02</org_study_id>
    <nct_id>NCT04850326</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet</brief_title>
  <official_title>A Randomized, Cross-Over Clinical Study to Evaluate the Acute Efficacy of AP Green Tea Extract After a Meal Composed of High-Fat/High-Carbohydrate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amorepacific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amorepacific Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical trial is to evaluate the short term effects of single dose AP&#xD;
      green tea extracts in subjects with BMI (&lt; 30 kg/m2) and fasting glucose level of &gt; 100 mg/dL&#xD;
      after high-fat/high-carbohydrate meal.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 24, 2020</start_date>
  <completion_date type="Actual">February 26, 2021</completion_date>
  <primary_completion_date type="Actual">January 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Blood glucose level</measure>
    <time_frame>0 - 300 minute</time_frame>
    <description>Change of Blood glucose level before and after high-carbohydrate/high-fat meal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Insulin level</measure>
    <time_frame>0 - 300 minute</time_frame>
    <description>Change of Insulin level before and after high-carbohydrate/high-fat meal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Triglyceride level</measure>
    <time_frame>0 - 300 minute</time_frame>
    <description>Change of Triglyceride level before and after high-carbohydrate/high-fat meal</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Blood Glucose, High</condition>
  <arm_group>
    <arm_group_label>AP green tea extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AP green tea extract</intervention_name>
    <description>single intake of AP green tea extract</description>
    <arm_group_label>AP green tea extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects aged 19 years or over&#xD;
&#xD;
          -  BMI &lt; 30 kg/m2&#xD;
&#xD;
          -  Fasting glucose level &gt; 100 mg/dL (who is not under medication)&#xD;
&#xD;
          -  Subjects who voluntarily decide to participate in this clinical study and sign the&#xD;
             informed consent form on their own or through their representatives&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  At the screening visit, subjects who were diagnosed with obesity, diabetes,&#xD;
             dyslipidemia and undergoing medication&#xD;
&#xD;
          -  Subjects who were diagnosed with ventricular associated disease, unstable and&#xD;
             uncontrolled chronic medical disease, hyper/hypothyroidism, or active malignant tumor&#xD;
             and undergoing medication within 4 weeks prior to the first administration of the&#xD;
             investigational product&#xD;
&#xD;
          -  Subjects who have renal failure, acute or chronic hepatitis or known liver cirrhosis&#xD;
&#xD;
          -  In addition to the above, subjects who are determined to be ineligible to participate&#xD;
             in the clinical study according to the investigator's medical opinion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>KangBuk Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

